[Treatment possibilities for patients with advanced prostate cancer].

Abstract

Prostate cancer is the second leading cause of cancer-related death in Switzerland as well as in other western countries. For patients with advanced disease, ablation of androgens is regarded as optimal first-line treatment. But this treatment is palliative with a median duration of response of about 18 months and hormone refractory prostate cancer remains… (More)

Topics

Cite this paper

@article{Gillessen2006TreatmentPF, title={[Treatment possibilities for patients with advanced prostate cancer].}, author={Silke Gillessen and Florian Strasser}, journal={Therapeutische Umschau. Revue therapeutique}, year={2006}, volume={63 2}, pages={157-62} }